USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:14 PM 2012

NYSE 8091.35 8.37 Index Moved Up

NASDAQ 2928.15 12.29 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and CSKI...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

China Sky One Medical Inc.

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and China Sky One Medical Inc. in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.06

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Suggest

48.91

Intraday

One Month

^(0.31)

0.63%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.892B	Volume	141420
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.63%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.31
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

Illumina's Board Unanimously Rejects Roche's Offer; Shire Announces FDA ...

BioMedReports (subscription) - Feb 8, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

2012-02-07

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ...

MarketWatch (press release) - Feb 7, 2012

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals Announces FDA Priority Review Designation for Crofelemer NDA
- NCTechNews (press release)

2012-02-07

Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For Crofelemer NDA For Treatment Of Diarrhea

Reuters Key Development - Feb 7, 2012

2012-02-07

Salix Pharmaceuticals Crosses Above its 10-day MA (SLXP)

Financial News Network Online - Jan 31, 2012

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

2012-01-31

Salix Scores with Oral Relistor

2011-12-27

Salix Pharmaceuticals (SLXP): Zacks Rank Buy

2011-12-19

Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy

2011-11-28

1.44

Intraday

One Month

^0.02

1.41%

CSKI

NASDAQ

China Sky One Medical Inc.

P/E	1.58	P/B Ratio	0.13
Open	1.45	Day Low	1.43
Market Cap	24.4M	Volume	6100
Last Close	1.42	Short Ratio	12.60
Last Traded	2/9/2012	Year High	5.91
Percent Change	1.41%	EBITDA	26.7M
Year Low	0.89	Absolute Change	0.02
Book Value	10.844	EPS	0.897
Day High	1.45	Target Price	23.75
Current EPS	0.897	This Year EPS	Not Applicable
Current PE	1.58	This Year PE	Not Applicable

China Sky One Medical Inc Wins Bidding Process On Land Use Rights Covering Land At Song Bei District in Harbin

Reuters Key Development - Jul 19, 2011

2011-07-19

Robbins Umeda LLP Announces Investigation Of China Sky One Medical, Inc.

Reuters Key Development - Feb 17, 2011

2011-02-17

China Sky One Medical, Inc. Appoints New Chief Financial Officer

Reuters Key Development - Nov 23, 2010

2010-11-23

China Sky One Medical, Inc. Reiterates FY 2010 Outlook

Reuters Key Development - Nov 9, 2010

2010-11-08